The efficacy and safety of Simvastatin in the treatment of lipid abnormalities in diabetes mellitus
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Indian Journal of Endocrinology and Metabolism
- Vol. 17 (1) , 105-109
Abstract
Introduction: Notable lipid abnormalities in DM include elevated LDL-C which have been reported to be the prevalent lipid abnormality in DM and elevated total cholesterol levels. Although the Statins are widely used in the management of lipid abnormalities, their effects on the lipid abnormalities in Nigerians with DM has not been extensively evaluated. Objective: This report sets out to determine the effect of Simvor, a brand of Simvastatin in Nigerians with DM and abnormal lipid profiles. Materials and Methods: A total of 300 diabetic patients with abnormal lipid profile who were treatment naοve for lipid disorders were longitudinally recruited for the study. They were managed with Simvastatin (Simvor) in doses ranging from 20-40 mg alongside dietary counseling and exercise recommendation. Results: The mean age (SD) of the study subjects was 58.4 (10 years). The male; female ratio was 99:211. The proportions of lipid abnormalities for LDL-C, TCHOL, HDL-C and TG were 87%, 45%, 53% and 7% respectively. Following Simvastatin (Simvor) treatment, the mean LDL-C value was reduced by 16%, TCHOL by 23%, TG by 6% and HDL-C increased by 10%. Simvastatin (Simvor) was generally well tolerated and no cardiovascular events were noted in the study subjects during the period of the study. Conclusion: Simvastatin (Simvor) was effective and well tolerated in the management of lipid disorders in Nigerians with DM.Keywords
This publication has 14 references indexed in Scilit:
- Dyslipidaemia among Nigerian oil workers with type 2 diabetes mellitus.2011
- Characterization of lipid parameters in diabetes mellitus – a Nigerian reportInternational Archives of Medicine, 2009
- Pattern of dyslipidaemia among Nigerians with type 2 diabetes mellitus.2008
- Burden of diabetic illness in an urban hospital in NigeriaTropical Doctor, 2007
- Prognostic indices of diabetes mortality.2007
- Beyond Low-Density LipoproteinAmerican Journal of Cardiovascular Drugs, 2005
- The Global Burden of Chronic DiseasesJAMA, 2004
- Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patientsThe American Journal of Cardiology, 2003
- Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.2001
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998